Allopurinol Administration and Monitoring Guidelines

Critical Dosing Adjustments in Special Populations

The American College of Rheumatology recommends starting allopurinol at 50 mg/day in patients with stage 4 CKD or worse (eGFR <30 mL/min), regardless of whether the tablet is crushed or intact 1
For moderate renal impairment (eGFR 30-60 mL/min), the recommended starting dose is 100 mg/day maximum 1
Oxypurinol clearance decreases dramatically in renal impairment, from 1.8 L/h in normal function to 0.18 L/h in severe impairment 2

Gradually increase the dose by 50-100 mg increments every 2-5 weeks while monitoring serum uric acid levels, as recommended by the American College of Rheumatology 1, 3
The dose can be raised above 300 mg daily even with renal impairment, provided there is adequate monitoring for drug toxicity (pruritus, rash, elevated liver enzymes) 1, 3
Target serum uric acid <6 mg/dL, but achieve this gradually over weeks to months 3, 4

Check serum uric acid levels every 2-4 weeks during dose titration, as recommended by the American College of Rheumatology 3, 4
Monitor renal function (creatinine, eGFR) regularly, especially in patients with pre-existing kidney disease 3
Check liver function tests periodically during early therapy given the risk of hepatitis with allopurinol hypersensitivity syndrome 3

Watch for signs of allopurinol hypersensitivity syndrome: rash, pruritus, fever, eosinophilia, or worsening renal function, as recommended by the American College of Rheumatology 1, 3
Consider HLA-B*5801 testing before initiating therapy in high-risk populations (Korean patients with stage 3 or worse CKD; Han Chinese and Thai patients regardless of renal function) 1, 4

Do not start with standard 300 mg doses in patients with renal impairment, as this increases toxicity risk, as warned by the American College of Rheumatology 4
Do not fail to provide flare prophylaxis when initiating crushed allopurinol - use colchicine 0.3 mg daily or 0.6 mg every other day in severe renal impairment (eGFR <30) 3
Reduce doses of 6-mercaptopurine or azathioprine by 65-75% when used concomitantly with allopurinol (crushed or intact), as recommended by the American College of Rheumatology 3